{"id":"https://openalex.org/W2472322643","doi":null,"title":"Identification of cancer targets and therapeutics using phage display.","display_name":"Identification of cancer targets and therapeutics using phage display.","publication_year":2006,"publication_date":"2006-05-01","ids":{"openalex":"https://openalex.org/W2472322643","mag":"2472322643","pmid":"https://pubmed.ncbi.nlm.nih.gov/16729733"},"language":"en","primary_location":{"id":"pmid:16729733","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16729733","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024228161","display_name":"Renee E. Brissette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renee Brissette","raw_affiliation_strings":["Antyra Inc, 40 Talmadge Road, Edison, NJ 08818, USA. goldstein@antyra.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antyra Inc, 40 Talmadge Road, Edison, NJ 08818, USA. goldstein@antyra.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002582406","display_name":"John K A Prendergast","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John K A Prendergast","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056970679","display_name":"Neil I. Goldstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil I Goldstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.561,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.82481242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"9","issue":"3","first_page":"363","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.2782999873161316,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phage-display","display_name":"phage display","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cancer-targets","display_name":"cancer targets","score":0.5799999833106995},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.6959999799728394},{"id":"https://openalex.org/keywords/bioactive-peptides","display_name":"bioactive peptides","score":0.824999988079071},{"id":"https://openalex.org/keywords/agonists-and-antagonists","display_name":"agonists and antagonists","score":0.8650000095367432},{"id":"https://openalex.org/keywords/targeted-drugs","display_name":"targeted therapeutics","score":0.7670000195503235},{"id":"https://openalex.org/keywords/peptide-libraries","display_name":"peptide libraries","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C186268636","wikidata":"https://www.wikidata.org/wiki/Q896217","display_name":"Phage display","level":3,"score":0.9325822591781616},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6438385248184204},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6220353841781616},{"id":"https://openalex.org/C2776471321","wikidata":"https://www.wikidata.org/wiki/Q7166526","display_name":"Peptide library","level":4,"score":0.5060252547264099},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47258222103118896},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.467492014169693},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35836559534072876},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32815128564834595},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16161903738975525},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13338002562522888},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.12643367052078247},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09503421187400818},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001435","descriptor_name":"Bacteriophages","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019151","descriptor_name":"Peptide Library","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:16729733","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16729733","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},{"id":"mag:2472322643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16729733","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1485730287","https://openalex.org/W1526208457","https://openalex.org/W1834944463","https://openalex.org/W1950483962","https://openalex.org/W1966125619","https://openalex.org/W1974233660","https://openalex.org/W1986354324","https://openalex.org/W1987888718","https://openalex.org/W1993589090","https://openalex.org/W1998162097","https://openalex.org/W2001827801","https://openalex.org/W2005110237","https://openalex.org/W2008635725","https://openalex.org/W2014717030","https://openalex.org/W2035650745","https://openalex.org/W2036096376","https://openalex.org/W2038453174","https://openalex.org/W2049903695","https://openalex.org/W2050872235","https://openalex.org/W2073843513","https://openalex.org/W2075980472","https://openalex.org/W2084429764","https://openalex.org/W2085851286","https://openalex.org/W2096808952","https://openalex.org/W2097671323","https://openalex.org/W2099982459","https://openalex.org/W2102896820","https://openalex.org/W2110956170","https://openalex.org/W2111338227","https://openalex.org/W2113813607","https://openalex.org/W2114588239","https://openalex.org/W2125137272","https://openalex.org/W2129146146","https://openalex.org/W2134077476","https://openalex.org/W2139600968","https://openalex.org/W2140512094","https://openalex.org/W2141502931","https://openalex.org/W2144133200","https://openalex.org/W2149910292","https://openalex.org/W2163443807"],"related_works":["https://openalex.org/W2075888563","https://openalex.org/W4240369560","https://openalex.org/W2060335815","https://openalex.org/W2947027538","https://openalex.org/W2171940236","https://openalex.org/W2468325692","https://openalex.org/W116074379","https://openalex.org/W2912320219","https://openalex.org/W2359069950","https://openalex.org/W3031978121"],"abstract_inverted_index":{"Phage":[0],"display":[1,27,62],"is":[2,71],"a":[3],"well-established":[4],"approach":[5],"for":[6],"the":[7,16,72,79],"identification":[8],"of":[9,18,25,76,81],"bioactive":[10],"peptides":[11],"and":[12,45,58],"antibody":[13],"fragments":[14],"through":[15],"use":[17],"high":[19],"diversity":[20],"libraries.":[21],"One":[22],"major":[23],"advantage":[24],"phage":[26,61],"lies":[28],"in":[29,78],"its":[30],"ability":[31],"to":[32,66],"rapidly":[33],"identify":[34],"target-specific":[35],"reagents":[36],"with":[37],"pharmacological":[38],"activity":[39],"as":[40],"agonists":[41],"or":[42],"antagonists.":[43],"Peptides":[44],"antibodies":[46],"have":[47],"several":[48],"clinical":[49,74],"advantages":[50],"over":[51],"traditional":[52],"small-molecule":[53],"chemotherapeutics,":[54],"including":[55],"specificity,":[56],"selectivity":[57],"potency.":[59],"Thus,":[60],"can":[63],"be":[64],"used":[65],"generate":[67],"'targeted":[68],"therapeutics',":[69],"which":[70],"current":[73],"paradigm":[75],"choice":[77],"field":[80],"oncology.":[82]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}